Q32 Bio appoints new CMO and CDO
Q32 Bio announced the appointment of Dr. Jose Trevejo as CMO and Dr. Ellie Hershberger as CDO to drive its late-stage clinical pipeline and registration-directed program for alopecia areata.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day